Get the app!
Back to Trades

Schecter Alison D.

Chief Medical OfficerCIK 0001782448

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
1
Buy transactions
0
Sell transactions
0
Companies
1
Active
2026

Across 1 filing between 2026, Schecter Alison D., Chief Medical Officer, has disclosed $0 in transactions — all concentrated in Retension Pharmaceuticals, Inc. (RTSN). Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

1 loaded
Oct 8RTSN
Retension Pharmaceuticals, Inc.
Schecter Alison D.Chief Medical OfficerOther$0

1 filing